What it means
After a meal the intestine releases GLP-1, which tells the pancreas to release insulin, lowers glucagon, slows emptying of the stomach and makes a person feel full. GLP-1 receptor agonists, such as semaglutide, liraglutide and dulaglutide, are injected (one is also a tablet) for type 2 diabetestipe too dy-uh-BEE-teezA form of diabetes in which the body does not respond well to insulin and does not make enough of it to keep blood glucose normal.Full entry and weight loss. Common side effects are nausea, vomiting and constipation; rare risks include pancreatitis.
For the nurse
Teach the client to eat smaller meals and stop when full, and to report severe belly pain that spreads to the back. Because these drugs slow stomach emptying, the client should tell the surgical team they take one before surgery or sedation.
At a glance
| Also written | glucagon-like peptide-1 |
|---|
Related terms
insulin
A hormone made by the pancreas that lets the body's cells take in glucose, also made as a medicine.
glucose
A simple sugar that is the body's main source of energy.
type 2 diabetes
A form of diabetes in which the body does not respond well to insulin and does not make enough of it to keep blood glucose normal.